Skip to main content
Erschienen in: Journal of Neural Transmission 6/2015

01.06.2015 | Psychiatry and Preclinical Psychiatric Studies - Short communication

BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy

verfasst von: Alexandra Kleimann, Alexandra Kotsiari, Wolfgang Sperling, Michael Gröschl, Annemarie Heberlein, Kai G. Kahl, Thomas Hillemacher, Stefan Bleich, Johannes Kornhuber, Helge Frieling

Erschienen in: Journal of Neural Transmission | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

We examined potential changes in brain-derived neurotrophic factor (BDNF) serum levels and promoter methylation of the BDNF gene in 11 patients with treatment-resistant major depressive disorder during a series of electroconvulsive therapy (ECT). Blood samples were taken before, 1 and 24 h after ECT treatment sessions 1, 4, 7 and 10. Patients remitting under ECT had significantly lower mean promoter methylation rates, especially concerning the exon I promoter, compared to non-remitters (both p < 0.002). These findings may point to a depression subtype in which ECT is particularly beneficial.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Boulle F, van den Hove DL, Jakob SB, Rutten BP, Hamon M, van Os J, Lesch KP, Lanfumey L, Steinbusch HW, Kenis G (2012) Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry 17:584–596CrossRefPubMed Boulle F, van den Hove DL, Jakob SB, Rutten BP, Hamon M, van Os J, Lesch KP, Lanfumey L, Steinbusch HW, Kenis G (2012) Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry 17:584–596CrossRefPubMed
Zurück zum Zitat Brunoni AR, Baeken C, Machado-Vieira R, Gattaz WF, Vanderhasselt MA (2014) BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis. World J Biol Psychiatry 15:411–418CrossRefPubMed Brunoni AR, Baeken C, Machado-Vieira R, Gattaz WF, Vanderhasselt MA (2014) BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis. World J Biol Psychiatry 15:411–418CrossRefPubMed
Zurück zum Zitat Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, Coarfa C, Harris RA, Milosavljevic A, Troakes C, Al-Sarraj S, Dobson R, Schalkwyk LC, Mill J (2012) Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 13(6):R43. doi:10.1186/gb-2012-13-6-r43 CrossRefPubMedCentralPubMed Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, Coarfa C, Harris RA, Milosavljevic A, Troakes C, Al-Sarraj S, Dobson R, Schalkwyk LC, Mill J (2012) Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 13(6):R43. doi:10.​1186/​gb-2012-13-6-r43 CrossRefPubMedCentralPubMed
Zurück zum Zitat Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, Inoue T, Kusumi I, Koyama T, Tsuchiyama K, Terao T (2011) DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One 6:e23881CrossRefPubMedCentralPubMed Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, Inoue T, Kusumi I, Koyama T, Tsuchiyama K, Terao T (2011) DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One 6:e23881CrossRefPubMedCentralPubMed
Zurück zum Zitat Gedge L, Beaudoin A, Lazowski L, du Toit R, Jokic R, Milev R (2012) Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry 3:12CrossRefPubMedCentralPubMed Gedge L, Beaudoin A, Lazowski L, du Toit R, Jokic R, Milev R (2012) Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry 3:12CrossRefPubMedCentralPubMed
Zurück zum Zitat Hautzinger M, Keller F, Kühner C (2006) Beck-Depressions-Inventar BDI-II; manual. Harcourt Test Services, Frankfurt am Main Hautzinger M, Keller F, Kühner C (2006) Beck-Depressions-Inventar BDI-II; manual. Harcourt Test Services, Frankfurt am Main
Zurück zum Zitat Marano CM, Phatak P, Vemulapalli UR, Sasan A, Nalbandyan MR, Ramanujam S, Soekadar S, Demosthenous M, Regenold WT (2007) Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J Clin Psychiatry 68:512–517CrossRefPubMed Marano CM, Phatak P, Vemulapalli UR, Sasan A, Nalbandyan MR, Ramanujam S, Soekadar S, Demosthenous M, Regenold WT (2007) Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J Clin Psychiatry 68:512–517CrossRefPubMed
Zurück zum Zitat Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389CrossRefPubMed Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389CrossRefPubMed
Zurück zum Zitat Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539–7547PubMed Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539–7547PubMed
Zurück zum Zitat Tadic A, Muller-Engling L, Schlicht KF, Kotsiari A, Dreimuller N, Kleimann A, Bleich S, Lieb K, Frieling H (2014) Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. Mol Psychiatry 19:281–283CrossRefPubMed Tadic A, Muller-Engling L, Schlicht KF, Kotsiari A, Dreimuller N, Kleimann A, Bleich S, Lieb K, Frieling H (2014) Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. Mol Psychiatry 19:281–283CrossRefPubMed
Zurück zum Zitat Tsankova NM, Kumar A, Nestler EJ (2004) Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci 24:5603–5610CrossRefPubMed Tsankova NM, Kumar A, Nestler EJ (2004) Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci 24:5603–5610CrossRefPubMed
Metadaten
Titel
BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy
verfasst von
Alexandra Kleimann
Alexandra Kotsiari
Wolfgang Sperling
Michael Gröschl
Annemarie Heberlein
Kai G. Kahl
Thomas Hillemacher
Stefan Bleich
Johannes Kornhuber
Helge Frieling
Publikationsdatum
01.06.2015
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 6/2015
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-014-1336-6

Weitere Artikel der Ausgabe 6/2015

Journal of Neural Transmission 6/2015 Zur Ausgabe

Neurology and Preclinical Neurological Studies - Short communication

Subjective memory impairment and cholinergic transmission: a TMS study

Translational Neurosciences - Original Article

Dementia and Hopfield model

Neurology and Preclinical Neurological Studies - Original Article

Prediction of Parkinson’s disease subsequent to severe depression: a ten-year follow-up study

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.